ArticleGenetic and Evolutionary Computation Conference : [proceedings]. Genetic and Evolutionary Computation Conference2026
Phase-Alternation and Tree-Initialization to Facilitate Interpretable Rule-based Machine Learning.
Article in Genetic and Evolutionary Computation Conference : [proceedings]. Genetic and Evolutionary Computation Conference, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Interpretable machine learning is important for scientific, biomedical, and other high-stakes domains where transparency, trust, and human understanding of models are required. Recently, an evolutionary rule-based machine learning algorithm called HEROS was proposed, which separated rule from rule-set discovery each with distinct multi-objective optimization strategies yielding a two-phase, noise agnostic framework that found accurate, highly compact, and interpretable solutions on a diverse set of challenging benchmarks without requiring hyperparameter optimizations. However, HEROS is currently limited by its strictly sequential two-phase design which requires committing in advance to a fixed number of rule-discovery iterations. This work extends HEROS with a phase alternation scheme interleaving rule discovery and rule-set optimization. This enables refinement of both tasks throughout training in an 'anytime-algorithm' manner. We also introduce a tree-based rule initialization strategy to accelerate early-stage rule discovery. These extensions aim to preserve the empirical performance of the original HEROS framework under a similar computational budget while providing greater flexibility for algorithm application and problem scalability. Using the same diverse set of benchmark datasets, we evaluate and compare these HEROS extensions to the original HEROS algorithm and established rule-based learning systems including RIPPER and BioHEL. We demonstrate the advantages of this extended HEROS framework.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.